Akero Therapeutics
AKRO
AKRO
103 hedge funds and large institutions have $499M invested in Akero Therapeutics in 2022 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 35 increasing their positions, 25 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.71% less ownership
Funds ownership: 101.23% → 100.52% (-0.71%)
33% less capital invested
Capital invested by funds: $746M → $499M (-$247M)
100% less call options, than puts
Call options by funds: $1K | Put options by funds: $460K
Holders
103
Holding in Top 10
4
Calls
$1K
Puts
$460K
Top Buyers
| 1 | +$5.05M | |
| 2 | +$2.93M | |
| 3 | +$2.91M | |
| 4 |
IHAM
Integral Health Asset Management
New York
|
+$1.63M |
| 5 |
Morgan Stanley
New York
|
+$1.39M |
Top Sellers
| 1 | -$9.99M | |
| 2 | -$9.56M | |
| 3 | -$1.88M | |
| 4 |
Alkeon Capital Management
New York
|
-$851K |
| 5 |
BlackRock
New York
|
-$690K |